Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) PS Ratio: 0.17

Is Cencora, Inc.’s P/S ratio high or low?

Cencora, Inc.'s P/S ratio of 0.17 is in line with its 5-year average of 0.16, around the middle of its 5-year range (0.11–0.23).

As of Saturday, June 13, 2026. 12.45% below its 12-month average of 0.19.

COR PS Ratio Chart

COR PS Ratio
0.17-10.53% 1Y
Zoom

COR Average PS Ratio Chart

COR Current vs Average PS Ratio Chart

COR PS Ratio Metrics

PS RATIO

0.17

PS RATIO AVG TTM

0.19

PS RATIO AVG 3Y

0.17

PS RATIO AVG 5Y

0.16

PS RATIO AVG 10Y

0.14

PS RATIO AVG 15Y

0.14

PS RATIO AVG 20Y

0.14

CURRENT VS TTM AVG

-12.45%

CURRENT VS 3Y AVG

-2.60%

CURRENT VS 5Y AVG

+7.49%

CURRENT VS 10Y AVG

+24.02%

CURRENT VS 15Y AVG

+18.79%

CURRENT VS 20Y AVG

+24.29%

COR Competitors' PS Ratio

NAMEMARKET CAPPS RATIOTTM3Y5Y
Cencora, Inc. (COR)$54.80B0.170.190.170.16
Becton, Dickinson and Company (BDX)$52.98B1.922.022.502.66
Regeneron Pharmaceuticals, Inc. (REGN)$63.06B4.425.036.556.20
Humana Inc. (HUM)$45.53B0.330.240.360.49
IDEXX Laboratories, Inc. (IDXX)$44.24B10.1812.1111.2912.11
Agilent Technologies, Inc. (A)$36.67B5.105.305.535.97
Zoetis Inc. (ZTS)$33.36B3.536.078.189.34
Centene Corporation (CNC)$32.19B0.160.110.190.25
Medline Inc. (MDLN)$30.96B1.041.221.221.22
Cigna Corporation (CI)$78.83B0.280.290.390.42

P/S vs. its own history

At 0.17, P/S is richer than usual, sitting higher than 87% of its 20-year history.

20-year low

0.06

median

0.13

20-year high

0.23

cheaperricher

Sales Valuation

P/S Ratio

0.17

Market Cap / Annual Revenue

Cencora, Inc. PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Cencora, Inc. PS Ratio FAQ

What is the P/S ratio for Cencora, Inc. (COR)?
The P/S ratio for COR stock is 0.17.
Is Cencora, Inc.'s P/S ratio high or low?
Cencora, Inc.'s P/S ratio of 0.17 is in line with its 5-year average of 0.16, around the middle of its 5-year range (0.11–0.23).
What is the TTM average P/S ratio for Cencora, Inc. (COR)?
The TTM average P/S ratio for COR stock is 0.19.
What is the 3Y average P/S ratio for Cencora, Inc. (COR)?
The 3Y average P/S ratio for COR stock is 0.17.
What is the 5Y average P/S ratio for Cencora, Inc. (COR)?
The 5Y average P/S ratio for COR stock is 0.16.
What is the 10Y average P/S ratio for Cencora, Inc. (COR)?
The 10Y average P/S ratio for COR stock is 0.14.
What is the 15Y average P/S ratio for Cencora, Inc. (COR)?
The 15Y average P/S ratio for COR stock is 0.14.
What is the 20Y average P/S ratio for Cencora, Inc. (COR)?
The 20Y average P/S ratio for COR stock is 0.14.

Cencora, Inc. PS Ratio History

DATEPS RATIO
2026-06-120.17
2026-06-110.17
2026-06-100.17
2026-06-090.17
2026-06-080.16
2026-06-050.16
2026-06-040.16
2026-06-030.16
2026-06-020.16
2026-06-010.16
2026-05-290.16
2026-05-280.16
2026-05-270.16
2026-05-260.16
2026-05-220.16
2026-05-210.16
2026-05-200.16
2026-05-190.16
2026-05-180.16
2026-05-150.15
2026-05-140.16
2026-05-130.15
2026-05-120.16
2026-05-110.15
2026-05-080.16
2026-05-070.15
2026-05-060.15
2026-05-050.18
2026-05-040.18
2026-05-010.18
2026-04-300.18
2026-04-290.19
2026-04-280.19
2026-04-270.19
2026-04-240.18
2026-04-230.19
2026-04-220.18
2026-04-210.19
2026-04-200.19
2026-04-170.20
2026-04-160.19
2026-04-150.19
2026-04-140.19
2026-04-130.19
2026-04-100.19
2026-04-090.19
2026-04-080.19
2026-04-070.19
2026-04-060.19
2026-04-020.19
2026-04-010.19
2026-03-310.19
2026-03-300.19
2026-03-270.19
2026-03-260.19
2026-03-250.19
2026-03-240.20
2026-03-230.19
2026-03-200.20
2026-03-190.20
2026-03-180.19
2026-03-170.20
2026-03-160.21
2026-03-130.21
2026-03-120.21
2026-03-110.21
2026-03-100.21
2026-03-090.22
2026-03-060.21
2026-03-050.22
2026-03-040.22
2026-03-030.22
2026-03-020.22
2026-02-270.22
2026-02-260.22
2026-02-250.22
2026-02-240.22
2026-02-230.22
2026-02-200.22
2026-02-190.22
2026-02-180.22
2026-02-170.22
2026-02-130.22
2026-02-120.21
2026-02-110.22
2026-02-100.22
2026-02-090.22
2026-02-060.22
2026-02-050.21
2026-02-040.20
2026-02-030.22
2026-02-020.22
2026-01-300.22
2026-01-290.21
2026-01-280.21
2026-01-270.21
2026-01-260.21
2026-01-230.21
2026-01-220.21
2026-01-210.21
2026-01-200.21
2026-01-160.21
2026-01-150.21
2026-01-140.21
2026-01-130.21
2026-01-120.21
2026-01-090.20
2026-01-080.20
2026-01-070.21
2026-01-060.21
2026-01-050.21
2026-01-020.20
2025-12-310.20
2025-12-300.21
2025-12-290.21
2025-12-260.21
2025-12-240.21
2025-12-230.21
2025-12-220.21
2025-12-190.21
2025-12-180.21
2025-12-170.21
2025-12-160.21
2025-12-150.21
2025-12-120.21
2025-12-110.21
2025-12-100.21
2025-12-090.20
2025-12-080.20
2025-12-050.20
2025-12-040.20
2025-12-030.20
2025-12-020.21
2025-12-010.22
2025-11-280.22
2025-11-260.22
2025-11-250.23
2025-11-240.23
2025-11-210.23
2025-11-200.22
2025-11-190.22
2025-11-180.22
2025-11-170.23
2025-11-140.22
2025-11-130.23
2025-11-120.22
2025-11-110.23
2025-11-100.22
2025-11-070.22
2025-11-060.22
2025-11-050.22
2025-11-040.21
2025-11-030.21
2025-10-310.21
2025-10-300.21
2025-10-290.21
2025-10-280.21
2025-10-270.21
2025-10-240.21
2025-10-230.20
2025-10-220.20
2025-10-210.20
2025-10-200.20
2025-10-170.20
2025-10-160.20
2025-10-150.20
2025-10-140.20
2025-10-130.20
2025-10-100.20
2025-10-090.19
2025-10-080.19
2025-10-070.19
2025-10-060.19
2025-10-030.19
2025-10-020.19
2025-10-010.19
2025-09-300.19
2025-09-290.19
2025-09-260.19
2025-09-250.18
2025-09-240.19
2025-09-230.19
2025-09-220.18
2025-09-190.18
2025-09-180.18
2025-09-170.18
2025-09-160.18
2025-09-150.18
2025-09-120.19
2025-09-110.19
2025-09-100.18
2025-09-090.18
2025-09-080.18
2025-09-050.18
2025-09-040.18
2025-09-030.18
2025-09-020.18
2025-08-290.18
2025-08-280.18
2025-08-270.18
2025-08-260.18
2025-08-250.18
2025-08-220.18
2025-08-210.19
2025-08-200.19
2025-08-190.18
2025-08-180.18
2025-08-150.18
2025-08-140.18
2025-08-130.18
2025-08-120.18
2025-08-110.18
2025-08-080.18
2025-08-070.17
2025-08-060.17
2025-08-050.18
2025-08-040.18
2025-08-010.18
2025-07-310.18
2025-07-300.18
2025-07-290.18
2025-07-280.18
2025-07-250.18
2025-07-240.18
2025-07-230.18
2025-07-220.18
2025-07-210.18
2025-07-180.18
2025-07-170.19
2025-07-160.19
2025-07-150.19
2025-07-140.19
2025-07-110.19
2025-07-100.19
2025-07-090.19
2025-07-080.19
2025-07-070.19
2025-07-030.19
2025-07-020.18
2025-07-010.19
2025-06-300.19
2025-06-270.19
2025-06-260.19
2025-06-250.18
2025-06-240.18
2025-06-230.18
2025-06-200.18
2025-06-180.19
2025-06-170.18
2025-06-160.18
2025-06-130.19
2025-06-120.19
2025-06-110.18
2025-06-100.18
2025-06-090.18
2025-06-060.18
2025-06-050.18
2025-06-040.18
2025-06-030.18
2025-06-020.18

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch